Generation of RB1 knockout human embryonic stem cell lines derived from H9 using CRISPR/Cas9

Area of Science:

• Stem cell biology
• Cancer genetics
• Molecular biology

Background:

• The RB1 gene is a critical tumor suppressor involved in cell cycle control and differentiation.
• Loss or mutation of RB1 is linked to retinoblastoma and other cancers.

Purpose of the Study:

• To generate and characterize RB1 knockout human embryonic stem cell (hESC) lines.
• To provide models for studying RB1's role in tumorigenesis, neurodevelopment, and cell cycle regulation.

Main Methods:

• CRISPR/Cas9-mediated gene targeting was used to create RB1 knockout hESC lines (H9).
• Characterization involved assessing stem cell morphology, karyotype, pluripotency markers, and in vivo differentiation capacity.

Main Results:

• RB1-deficient hESC lines maintained normal stem cell characteristics, including morphology, karyotype, and pluripotency marker expression.
• These knockout cells demonstrated retained in vivo differentiation capacity, generating multiple cell lineages.

Conclusions:

• The generated RB1 knockout hESC lines serve as valuable tools for cancer research and understanding neurodevelopment.
• These models facilitate investigations into the functional roles of RB1 in cell cycle regulation and disease.